Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer

scientific article

Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/PR4001527
P932PMC publication ID4142215
P698PubMed publication ID23647160
P5875ResearchGate publication ID236640993

P50authorGil OmennQ5560581
Matan HofreeQ87906411
Massimo CristofanilliQ91695610
Trey IdekerQ16335202
Michael P. SnyderQ28924918
Susan FanayanQ38639422
P2093author name stringZhaomei Mu
Ronald C Beavis
William S Hancock
Young-Ki Paik
Shiaw-Lin Wu
Seul-Ki Jeong
James M Reuben
Hogune Im
Emma Yue Zhang
Anna Fan Zhang
Fredika Robertson
P2860cites workMapping and quantifying mammalian transcriptomes by RNA-SeqQ22122035
Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA)Q24294659
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4Q24318320
A census of human cancer genesQ24647081
Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolutionQ24676904
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferationQ24678674
Comparing protein abundance and mRNA expression levels on a genomic scaleQ24682985
Targeting RAS signalling pathways in cancer therapyQ28201363
Effects of methylation on expression of TMS1/ASC in human breast cancer cellsQ28207669
An unconventional pathway for reduction of CO2 to methane in CO-grown Methanosarcina acetivorans revealed by proteomicsQ28273832
Personal omics profiling reveals dynamic molecular and medical phenotypesQ29614800
CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.Q30010476
Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctionsQ30165423
An approach to the proteomic analysis of a breast cancer cell line (SKBR-3).Q30780232
Significance analysis of spectral count data in label-free shotgun proteomicsQ31164168
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerQ33303529
Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patientsQ33390513
BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell linesQ33523959
The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapyQ33592958
The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.Q34080000
The EGF receptor family as targets for cancer therapyQ34293543
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexQ34314489
Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genesQ34354173
Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migrationQ34791886
Identifying and validating causal genetic alterations in human breast cancerQ35130673
A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteomeQ35140579
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancerQ35759154
Epigenetic silencing of 14-3-3sigma in cancerQ36477686
Molecular cytogenetic analysis of 11 new breast cancer cell linesQ36619975
Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cellsQ36626059
Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell lineQ36832476
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cellsQ37131339
Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.Q37131357
Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cellsQ37383705
The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancerQ37630052
Dual HER2-targeted approaches in HER2-positive breast cancerQ37940203
Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survivalQ38426352
Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patientsQ38517823
Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.Q39820488
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibitionQ39844747
A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markersQ40003301
Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motilityQ40156318
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.Q40303976
Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies.Q40475728
Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell linesQ40612612
The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cellsQ41575100
The role of S100 genes in breast cancer progressionQ42481244
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsQ42519924
In Silico Protein Interaction Analysis Using the Global Proteome Machine DatabaseQ42681450
Mammalian housekeeping genes evolve more slowly than tissue-specific genesQ48221814
Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive TumorsQ53375722
Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines.Q55135279
Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survivalQ57713449
Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cellsQ72069277
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarraysQ77220709
Uniting ENCODE with genome-wide proteomicsQ85397381
Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genesQ87377000
P433issue6
P921main subjectErb-b2 receptor tyrosine kinase 2Q415271
RNA sequencingQ2542347
inflammatory breast cancerQ5922406
P304page(s)2805-2817
P577publication date2013-05-22
P1433published inJournal of Proteome ResearchQ3186939
P1476titleGenome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer
P478volume12

Reverse relations

cites work (P2860)
Q34010823A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines
Q40738932BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
Q35867159Branched-Chain Aminotransferases Control TORC1 Signaling in Saccharomyces cerevisiae
Q34080008Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform
Q37619141Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes
Q38938061Identification of frequent somatic mutations in inflammatory breast cancer
Q54281598Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Q38402575Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues
Q53462538Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Q36703120MI-PVT: A Tool for Visualizing the Chromosome-Centric Human Proteome
Q34664059Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.
Q30834972Novel bioinformatics method for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Q36992268Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins
Q34556822Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide
Q27014674Targeting SH2 domains in breast cancer
Q48597281The chromosome-centric human proteome project at FEBS Congress
Q37215538The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease
Q38296676The role of CT10 regulation of kinase-like in cancer
Q92942425The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma

Search more.